Centiva Capital’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Buy
200,095
+46,213
+30% +$63.7K ﹤0.01% 1253
2026
Q1
$199K Buy
153,882
+135,337
+730% +$224K ﹤0.01% 1280
2025
Q4
$41K Buy
+18,545
New +$34.9K ﹤0.01% 1165
2025
Q2
Sell
-14,233
Closed -$95.8K 1852
2025
Q1
$95.8K Buy
+14,233
New +$101K ﹤0.01% 1404
2024
Q3
Sell
-26,850
Closed -$170K 2411
2024
Q2
$170K Buy
+26,850
New +$206K ﹤0.01% 1735

Other funds holding LUNG

Centiva Capital's LUNG Position: Q2 2026 in Review

Centiva Capital increased its Pulmonx (LUNG) stake by 30% in Q2 2026, buying an estimated $63.7K and bringing the position to 200,095 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

Centiva Capital first reported a position in LUNG in Q2 2024 and has held it in 5 quarters since. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Centiva Capital held 200,095 shares of Pulmonx worth $260K as of Q2 2026.
  • Centiva Capital bought 46,213 Pulmonx shares in Q2 2026, an estimated $63.7K.
  • Pulmonx made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1253 holding.
  • Centiva Capital first reported a position in Pulmonx in Q2 2024 and has held it in 5 quarters since.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.